Home > Journals > Minerva Obstetrics and Gynecology > Past Issues > Minerva Obstetrics and Gynecology 2021 June;73(3) > Minerva Obstetrics and Gynecology 2021 June;73(3):369-75

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Minerva Obstetrics and Gynecology 2021 June;73(3):369-75

DOI: 10.23736/S2724-606X.21.04773-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Spontaneous and induced chromosomal aberrations in peripheral blood of women with endometriosis: evidence of genomic instability

Parnaz BORJIAN BOROUJENI 1, Zahra BEHESHTI 1, Seyedeh H. ESHAGHI ZADEH 1, Parvaneh AFSHARIAN 1, Anahita MOHSENI MEYBODI 1, 2

1 Department of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran; 2 Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada



BACKGROUND: Endometriosis is a prevalent gynecological disease which can lead to certain types of cancers. We investigated the spontaneous and induced chromosomal aberrations in peripheral blood lymphocytes (PBL) of endometriosis patients.
METHODS: We performed a pilot study utilizing mitomycin C (MMC) to assess chromosomal instability in the peripheral blood of participants. The patient group consisted of 20 infertile endometriosis patients and the controls of 20 healthy fertile women. Blood samples were collected, and two distinct lymphocyte cultures were prepared to evaluate the baseline and the MMC induced chromosomal aberrations.
RESULTS: The results showed a significant difference before and after MMC treatment in both groups (P<0.001) and also revealed that endometriosis patients are far more sensitive to MMC than controls (P<0.001).
CONCLUSIONS: The significantly higher frequency of induced and spontaneous chromosomal aberrations in patients can be consider as a sign of genomic instability and the defect in DNA repair mechanisms, which can be both assumed as a driver of cancer development in endometriosis patients.


KEY WORDS: Endometriosis; Mitomycin; Chromosome aberrations

top of page